What should we expect as far as weight gain, risk of hypoglycemia, and degree of HA1c lowering with fixed ratio combinations such a iGlarLixi and iDegLira?

What should we expect as far as weight gain, risk of hypoglycemia, and degree of HA1c lowering with fixed ratio combinations such a iGlarLixi and iDegLira?

What should we expect as far as weight gain, risk of hypoglycemia, and degree of HA1c lowering with fixed ratio combinations such a iGlarLixi and iDegLira?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Derek LeRoith, MD, PhD

Derek LeRoith, MD, PhD

Professor of Medicine Director of Research in the Division of Endocrinology, Diabetes and Bone Diseases Mount Sinai School of Medicine New York, New York